VCNX OTC
Vaccinex, Inc.
1W: +4.1%
1M: +1.0%
3M: -9.8%
YTD: -10.6%
1Y: +62.9%
3Y: -93.6%
5Y: -99.8%
$1.01
+0.01 (+1.00%)
Weekly Expected Move ±22.3%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$601K
+5.4% ▲
5Y CAGR: +2.8%
Gross Profit
$601K
+5.4% ▲
5Y CAGR: +13.2%
Operating Income
-$19M
+18.1% ▲
Net Income
-$19M
+8.0% ▲
EPS (Diluted)
$-8.88
+79.7% ▲
EBITDA
-$19M
+6.1% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $50K | $900K | $100K | $570K | $601K |
| YoY Growth | -90.4% | +1700.0% | -88.9% | +470.0% | +5.4% |
| Cost of Revenue | $2K | $169K | $207K | $0 | $0 |
| Gross Profit | $48K | $731K | $68K | $570K | $601K |
| Gross Margin | 96.0% | 81.2% | 68.0% | 100.0% | 100.0% |
| R&D Expenses | $22M | $17M | $14M | $17M | $13M |
| SG&A Expenses | $7M | $6M | $6M | $7M | $7M |
| Operating Expenses | $28M | $23M | $20M | $23M | $19M |
| Operating Income | -$28M | -$22M | -$20M | -$23M | -$19M |
| Operating Margin | -56662.0% | -2498.9% | -19906.0% | -4014.9% | -3117.3% |
| Interest Expense | $489K | $809K | $2K | $1K | $2K |
| Income Before Tax | -$29M | -$22M | -$20M | -$20M | -$19M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$29M | -$22M | -$20M | -$20M | -$19M |
| Net Margin | -57702.0% | -2486.7% | -19722.0% | -3552.8% | -3100.5% |
| EPS (Diluted) | $-322.50 | $-162.91 | $-97.59 | $-43.68 | $-8.88 |
| EBITDA | -$28M | -$21M | -$20M | -$20M | -$19M |
| Shares Outstanding | 89461 | 137377 | 202082 | 463650 | 2M |